LALPATHLAB

Dr. Lal Path Labs Ltd.NSE
₹1,912.5+10.60 (+0.56%)

Market Closed · NSE · INR

Open

₹1,881.4

High

₹1,920

Low

₹1,881.4

Prev Close

₹1,901.9

52-Week Range92% from low
₹1,307.6
₹1,968.4

Market Cap

₹31.76 K Cr

Large Cap

P/E (TTM)

58.13

EPS

₹32.72

Div Yield

0.84%

P/B Ratio

12.57

ROE

21.5%

Key Metrics

Forward P/E43.69
Book Value₹152.19
Debt/Equity0.00×
Revenue Growth19.1%
Profit Margin18.90%
Operating Margin28.32%
Volume90.5 K
Avg Volume (20d)1.91 L
Delivery %55.31%
Trades13,660

Analyst Ratings(26 analysts)

Buy

Target Price

₹1,952

+2.1% upside

Strong Buy4
Buy16
Hold3
Sell2
Strong Sell1
Low: ₹1,180Median: ₹2,020High: ₹2,300

Current price: ₹1,913

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDiagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, vi...

lalpathlabs.com5,206 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 19.50/share
25
26
26
26
30 Jul 20265.00
25 Jun 20264.00
05 Feb 20263.50
07 Nov 20257.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.